Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

COVID-19 shots to the people: Indonesia city revs up vaccine buses

Published 13/06/2021, 10:25
Updated 13/06/2021, 11:06
© Reuters. Public buses, used as a coronavirus disease (COVID-19) vaccination venue, are seen parked outside the Madani hospital in Pekanbaru, Riau province, Indonesia, June 8, 2021.  REUTERS/Stringer

PEKANBARU, Indonesia (Reuters) - An Indonesian city is bringing COVID-19 vaccines to its people with a growing fleet of inoculation buses, as the country faces a spike in infections after a major religious festival.

Authorities in Pekanbaru on the island of Sumatra have doubled to 10 the number of buses in its vaccination programme, since launching it on June 1, following a favourable response from the public, who are happy with the convenience.

Indonesia, a sprawling archipelago of 270 million people, is bracing for a peak in coronavirus infections after the Eid al-Fitr festival last month that saw millions travel to visit family and friends.

"I hope this programme will keep continuing until all the people in this town get fully vaccinated," said Delvi, who like many Indonesians uses only one name, after getting a vaccine shot on the bus.

"It is closer and easier than the vaccination centre."

    The government of Pekanbaru, capital of Riau province, says the buses have administered 12,000 doses of China's Sinovac vaccine and are giving more than 1,000 shots a day. Authorities say they plan to increase the number of buses but have not said by how many.

Despite the interest in the bus project, authorities say they must fight misinformation about COVID-19 vaccinations.

"We saw some people had doubts about getting vaccinated because of fake news," said district chief Said Ahmad Zamzami.

"We inform them not to believe that and this vaccine is good for our immune system. People are also more convinced now because myself, as the head of the district, also participated," he said before getting his shot.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Indonesia plans to vaccinate 181.5 million people by next year. Only 11.57 million Indonesians have received two shots of the vaccines in use there: Sinovac, China's Sinopharm, or the Oxford AstraZeneca (NASDAQ:AZN) vaccine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.